VWA5A Polyclonal Antibody, FITC Conjugated

Background
May play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis.

Description
VWA5A Polyclonal Antibody, FITC Conjugated. FITC. Raised in: Rabbit.

Formulation
Liquid. 0.03% Proclin 300. 50% Glycerol, 0.01M PBS, pH 7.4.

Specificity
Human

Isotype
IgG

Uniprot ID
O00534

Purification
Affinity purified

Immunogen
Recombinant Human von Willebrand factor A domain-containing protein 5A protein (1-415AA)

Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C (short-term) or -80°C (long-term). Avoid repeated freeze.

Alternative Names
von Willebrand factor A domain-containing protein 5A, VWA5A, BCSC1, LOH11CR2A, Breast cancer suppressor candidate 1, BCSC-1, Loss of heterozygosity 11 chromosomal region 2 gene A protein

Application
ELISA; Recommended dilution: ELISA 1:100-1:500